Demonstrates targeted cancer imaging in neuroblastomas and glioblastomas, highlighting a new imaging approach.
A fluorescent cyclic thioamide peptide has a serum half life over 8 hours and high selectivity for binding to Y 2 R receptor expressing cells, enabling imaging of neuroblastomas and glioblastomas.
No takes yet. Share an insight, caveat, or question.
Phan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: